Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy

2009 ◽  
Vol 81 (4) ◽  
pp. 610-618 ◽  
Author(s):  
Wassim Chehadeh ◽  
Widad Al-Nakib
Keyword(s):  
Chronic Hepatitis ◽  
Liver Disease ◽  
Hepatitis B ◽  
Antiviral Therapy ◽  
Sustained Virological Response ◽  
Chronic Hepatitis B ◽  
Virological Response ◽  
Glucose Abnormalities

About Results of Successive Application Two «Strategies» of Antiviral Therapy of Chronic Hepatitis B Patients

2016 ◽  
pp. 158-160
Author(s):  
Nihiar Nagiyeva ◽  
Murad Mamedov
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Antiviral Therapy ◽  
Sustained Virological Response ◽  
Chronic Hepatitis B ◽  
Virological Response ◽  
Clinical Observation

The authors presented main results of their clinical observation for 128 chronic hepatitis B (CHB), which underwent antiviral therapy with pegilated interferon for 6 months. 44,5% of these patients had sustained virological response (SVR). Then 55,5% patients who after therapy had no SVR were additionally treated with one of nucleosides analog for 18 month. Finally 6 month later after end of second therapy SVR was registered at more than 90% of CHB patients.

scholarly journals Use of on-Treatment HBsAg Level and HBeAg Index Can Early Predict Sustained Virological Response in Chronic Hepatitis B, HBeAg Positive Patients Treated With Peginterferon ALPHA-2A

2011 ◽  
Vol 140 (5) ◽  
pp. S-931
Author(s):  
Pochamana Phisalprapa ◽  
Phunchai Charatcharoenwitthaya ◽  
Siwaporn P. Chainuvati ◽  
Supot Nimanong ◽  
Nonthalee Pausawasdi ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Sustained Virological Response ◽  
Chronic Hepatitis B ◽  
Virological Response ◽  
Hbsag Level
Sign in / Sign up

Export Citation Format

Share Document